Literature DB >> 16699021

Inhibition of DNA replication of human papillomavirus by artificial zinc finger proteins.

Takashi Mino1, Takeaki Hatono, Naoki Matsumoto, Tomoaki Mori, Yusuke Mineta, Yasuhiro Aoyama, Takashi Sera.   

Abstract

Recently, we demonstrated that plant DNA virus replication was inhibited in planta by using an artificial zinc finger protein (AZP) and created AZP-based transgenic plants resistant to DNA virus infection. Here we apply the AZP technology to the inhibition of replication of a mammalian DNA virus, human papillomavirus type 18 (HPV-18). Two AZPs, designated AZP(HPV)-1 and AZP(HPV)-2, were designed by using our nondegenerate recognition code table and were constructed to block binding of the HPV-18 E2 replication protein to the replication origin. Both of the newly designed AZPs had much higher affinities towards the replication origin than did the E2 protein, and they efficiently blocked E2 binding in vitro. In transient replication assays, both AZPs inhibited viral DNA replication, especially AZP(HPV)-2, which reduced the replication level to approximately 10%. We also demonstrated in transient replication assays, using plasmids with mutant replication origins, that AZP(HPV)-2 could precisely recognize the replication origin in mammalian cells. Thus, it was demonstrated that the AZP technology could be applied not only to plant DNA viruses but also to mammalian DNA viruses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699021      PMCID: PMC1472147          DOI: 10.1128/JVI.01795-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Identification of sequence requirement for the origin of DNA replication in human papillomavirus type 18.

Authors:  D Lee; H Kim; Y Lee; J Choe
Journal:  Virus Res       Date:  1997-11       Impact factor: 3.303

2.  Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins.

Authors:  T Yasugi; J D Benson; H Sakai; M Vidal; P M Howley
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein.

Authors:  M G Frattini; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18.

Authors:  M Remm; R Brain; J R Jenkins
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

5.  Transient replication of human papillomavirus DNAs.

Authors:  A M Del Vecchio; H Romanczuk; P M Howley; C C Baker
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Replication of human papillomavirus (HPV) DNAs supported by the HPV type 18 E1 and E2 proteins.

Authors:  F Sverdrup; S A Khan
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA.

Authors:  F Sverdrup; S A Khan
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  cis-Acting components of human papillomavirus (HPV) DNA replication: linker substitution analysis of the HPV type 11 origin.

Authors:  J Russell; M R Botchan
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

10.  Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts.

Authors:  S R Kuo; J S Liu; T R Broker; L T Chow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

View more
  9 in total

1.  Inhibition of DNA replication of human papillomavirus by using zinc finger-single-chain FokI dimer hybrid.

Authors:  Takashi Mino; Tomoaki Mori; Yasuhiro Aoyama; Takashi Sera
Journal:  Mol Biotechnol       Date:  2014-08       Impact factor: 2.695

2.  Hypoxia-specific downregulation of endogenous human VEGF-A gene by hypoxia-driven expression of artificial transcription factor.

Authors:  Tomoaki Mori; Jun Sasaki; Yasuhiro Aoyama; Takashi Sera
Journal:  Mol Biotechnol       Date:  2010-10       Impact factor: 2.695

3.  Inhibiting replication of begomoviruses using artificial zinc finger nucleases that target viral-conserved nucleotide motif.

Authors:  Wei Chen; Yongsheng Qian; Xiaoyun Wu; Yuqiang Sun; Xiaoxia Wu; Xiaofei Cheng
Journal:  Virus Genes       Date:  2014-01-29       Impact factor: 2.332

Review 4.  Rationalizing the development of live attenuated virus vaccines.

Authors:  Adam S Lauring; Jeremy O Jones; Raul Andino
Journal:  Nat Biotechnol       Date:  2010-06-07       Impact factor: 54.908

Review 5.  Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.

Authors:  Edward M Kennedy; Bryan R Cullen
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

6.  The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells.

Authors:  Stacy M Horner; Daniel DiMaio
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

7.  Gene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus.

Authors:  Takashi Mino; Tomoaki Mori; Yasuhiro Aoyama; Takashi Sera
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 8.  Designer nucleases to treat malignant cancers driven by viral oncogenes.

Authors:  Tristan A Scott; Kevin V Morris
Journal:  Virol J       Date:  2021-01-13       Impact factor: 4.099

9.  Expression, purification and molecular analysis of the human ZNF706 protein.

Authors:  Jucimara Colombo; Paola Jocelan Scarin Provazzi; Marilia Freitas Calmon; Lilian Campos Pires; Nathália Campos Rodrigues; Paulo Petl; Marcelo Andrés Fossey; Fátima Pereira de Souza; Fernanda Canduri; Paula Rahal
Journal:  Biol Proced Online       Date:  2013-09-23       Impact factor: 3.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.